Screening Nasopharyngeal Carcinoma With EBV Associated Biomarkers in Zhongshan City
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The study includes two cohorts: (1) a serological screening cohort; (2) a serological and EBV DNA screening cohort. All participants will be tested for EBNA1-IgA, VCA-IgA, BNLF2b total antibodies (P85-Ab), with additional plasma EBV DNA testing in the latter cohort. Screening positive participants will be followed up annually. All subjects will also be followed by record linkage to Cancer Register and Population Register.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby mieszkające w mieście Zhongshan lub Wuzhou.
- •Osoby, które nie były leczone na raka nosogardzieli.
- •Osoby w dobrym ogólnym stanie zdrowia, zdolne do zrozumienia i podpisania zgody na udział w badaniu.
- •Osoby świadome i gotowe do współpracy podczas wizyt kontrolnych.
✗ Disqualifies
- •Osoby z poważnymi chorobami serca, wątroby lub nerek.
- •Osoby, u których istnieją przeciwwskazania do wykonania badania endoskopowego nosogardzieli.
Simplified criteria — AI translation
Trial details
- Minimum age
- 30 Years
- Maximum age
- 69 Years
- Last updated (source)
- September 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (2)
Zhongshan People's Hospital
Zhongshan, China
Wuzhou Red Cross Hospital
Wuzhou, China
Trial contact
Mingfang Ji, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/30/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.